Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:51:30.611Z.
Calculation as of: 2026-10-06T14:51:30.611Z.
Quote observation: 2026-10-06T14:36:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fc92921354a3baefe39f76a6e19d16813aeb2294e32cc7e27fab112852b36d76
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$50.92M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.44M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.16M
Free Cash Flow Yield
38.47%
TTM Avg
42.72%
3Y Avg
26.54%
5Y Avg
31.80%
Market Cap
$48.99M
Free Cash Flow Yield
N/A
TTM Avg
10.60%
3Y Avg
10.34%
5Y Avg
10.34%
Market Cap
$53.81M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Envoy Medical, Inc. (COCH) | $51.33M | N/A | N/A | N/A | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $50.92M | N/A | N/A | N/A | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.44M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $51.16M | 38.47% | 42.72% | 26.54% | 31.80% |
| INmune Bio, Inc. (INMB)vs › | $50.25M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $49.85M | N/A | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $53.09M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $48.99M | N/A | 10.60% | 10.34% | 10.34% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $53.81M | N/A | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $49.71M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
